Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New vitamin D analogs.

Eduardo Slatopolsky1, Jane Finch, Alex Brown

  • 1Renal Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Eslatopo@im.wustl.edu

Kidney International. Supplement
|May 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and determinants of cardiovascular disease in Indigenous populations.

Nature reviews. Cardiology·2026
Same author

Implementation of Evidence-Based, Person-Centered Alternative Delivery Models for Cardiac Rehabilitation in a Rural and Remote Population: The Country Heart Attack Prevention (CHAP) Project.

Heart, lung & circulation·2026
Same author

Synthetic Approach to Polymethine-Modified Trimethine Cyanines Gives Access to Viscosity-Sensitive Probes.

The Journal of organic chemistry·2026
Same author

Single-Cell RNA-Sequencing Reveals Cachectic Satellite Cell Population in Muscle of Male Mice With Cancer Cachexia.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Cultural, ethical, legal, and social considerations in genomics research with Indigenous Peoples: A scoping review.

European journal of human genetics : EJHG·2026
Same author

Total Pancreatectomy and Islet Auto Transplantation in South Australia: A Preliminary Evaluation of a 10-Year Experience.

The Medical journal of Australia·2026

New vitamin D analogs effectively treat secondary hyperparathyroidism with fewer side effects. 19-nor-1,25-(OH)2D2 shows promise for lower calcium and phosphate levels in patients.

Area of Science:

  • Endocrinology
  • Nephrology
  • Pharmacology

Background:

  • 1,25-(OH)2D3 (calcitriol) regulates parathyroid hormone (PTH) and parathyroid gland growth.
  • Calcitriol treats secondary hyperparathyroidism in renal failure but causes hypercalcemia and hyperphosphatemia.
  • This limits its therapeutic use due to adverse effects on calcium and phosphorus levels.

Purpose of the Study:

  • To evaluate novel vitamin D analogs for treating secondary hyperparathyroidism.
  • To identify analogs with potent PTH suppression and reduced calcemic/phosphatemic activity.
  • To compare the efficacy and safety of specific vitamin D analogs.

Main Methods:

  • Development and testing of vitamin D analogs, including 19-nor-1,25-(OH)2D2 and 1,alpha(OH)D2.
  • Assessment of PTH suppression and effects on calcium and phosphorus levels.

Related Experiment Videos

  • Comparative studies in animal models (rats) to evaluate calcemic and phosphatemic activity.

    • Main Results:

    • Four vitamin D analogs demonstrated PTH suppression with less calcemic and phosphatemic activity than calcitriol.
    • 19-nor-1,25-(OH)2D2 exhibited lower calcemic and phosphatemic activity compared to 1,alpha(OH)D2 in rats.
    • These analogs offer a potential therapeutic advantage over calcitriol.

    Conclusions:

    • 19-nor-1,25-(OH)2D2 may achieve a lower calcium x phosphorus product than 1,alpha(OH)D2, benefiting patient management.
    • Further research is needed to elucidate the mechanisms behind the differential actions of these vitamin D analogs.
    • These findings highlight the potential of specific vitamin D analogs in managing secondary hyperparathyroidism.